跳至主要内容
临床试验/JPRN-UMIN000012795
JPRN-UMIN000012795已完成未知

Effects of Tulobuterol Patch (Long acting beta-2 agonist) on dyspnea during exercise in patients with COPD - Effects of Tulobuterol Patch in COPD

Juntendo University Faculty of Medicine and graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2014年1月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

Tulobuterol patch produces significant improvement in dyspnea during exercise in stable COPD and may contribute to improve the quality of life in patients with COPD.

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with any of the following were excluded: 1)Bronchial asthma 2)Respiratory tract infection within the preceding 4 weeks 3)Respiratory failure with home oxygen therapy 4)who required oral corticosteroids 5)hypertension, heart disease, thyroid disease, diabetes, or skin disease and patients contraindicated to beta-2 agonists 6)Pregnant 7)others contraindicated to exercise

研究者

发起方
Juntendo University Faculty of Medicine and graduate School of Medicine

相似试验